Patents by Inventor Keith Albrandt

Keith Albrandt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6602694
    Abstract: A novel uncoupling protein, which we have designated UCP-4, that is expressed in various tissues, including brain, heart, pancreas, and muscle tissue, and nucleic acid molecules which encode for said novel protein, are described. Methods of screening for compounds that regulate the expression and the activity of UCP-4 are described, as well as methods of treating diseases or conditions in which the regulation of thermogenesis or respiratory ATP synthesis is desired. Such conditions include obesity, diabetes, malignant hyperthermia, and fever. The construction of cell lines that express UCP-4 is also described.
    Type: Grant
    Filed: June 27, 2001
    Date of Patent: August 5, 2003
    Assignee: Amylin Pharmaceuticals, Inc
    Inventors: Keith Albrandt, Kevin Beaumont, Andrew A. Young